ONE CROP
a non-food crop for biopharmaceuticals and biofuels
![](https://6e093d.p3cdn1.secureserver.net/wp-content/uploads/2016/09/Agragen_Icons_world-home-lg.png?time=1721907023)
AGRAGEN
Using environmentally friendly Camelina to produce biofuels for a greener world and biologic pharmaceuticals for the world’s health.
![](https://6e093d.p3cdn1.secureserver.net/wp-content/uploads/2016/09/Agragen_Icons_badge-white.png?time=1721907023)
WHO?
Agragen is a plant biotech and bioactive lipids company that uses Camelina Sativa as a platform to produce therapeutics in the open field. Agragen uses its expertise in Camelina transformation to produce bioactive lipids and therapeutic proteins while improving its agronomic performance.
![](https://6e093d.p3cdn1.secureserver.net/wp-content/uploads/2016/09/Agragen_Icons_plant-white.png?time=1721907023)
WHAT?
Camelina Sativa is a non-food, oil seed crop that is self-pollinating and produces seeds with a high protein and oil content. It is an excellent seed producer with limited potential for entering the food supply and little potential for cross-pollination with other plants. The high value meal is a great source of protein for downstream uses in poultry and aquaculture spaces.
![](https://6e093d.p3cdn1.secureserver.net/wp-content/uploads/2016/09/Agragen_Icons_dish-white.png?time=1721907023)
HOW?
Agragen uses its patented technology to express therapeutic proteins in the sprouting seed and bioactive lipids in the seed oil permitting large scale economical open field production.